Hims Hers Health Inc
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provi… Read more
Hims Hers Health Inc (HIMS) - Net Assets
Latest net assets as of September 2025: $580.98 Million USD
Based on the latest financial reports, Hims Hers Health Inc (HIMS) has net assets worth $580.98 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.23 Billion) and total liabilities ($1.65 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $580.98 Million |
| % of Total Assets | 26.01% |
| Annual Growth Rate | 65.97% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 306.82 |
Hims Hers Health Inc - Net Assets Trend (2018–2024)
This chart illustrates how Hims Hers Health Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Hims Hers Health Inc (2018–2024)
The table below shows the annual net assets of Hims Hers Health Inc from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $476.72 Million | +38.57% |
| 2023-12-31 | $344.03 Million | +10.36% |
| 2022-12-31 | $311.74 Million | -6.84% |
| 2021-12-31 | $334.62 Million | +327.83% |
| 2020-12-31 | $-146.87 Million | -8.56% |
| 2019-12-31 | $-135.29 Million | -693.55% |
| 2018-12-31 | $22.79 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Hims Hers Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 16102300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $22.00K | 0.00% |
| Other Comprehensive Income | $-324.00K | -0.07% |
| Other Components | $719.15 Million | 150.86% |
| Total Equity | $476.72 Million | 100.00% |
Hims Hers Health Inc Competitors by Market Cap
The table below lists competitors of Hims Hers Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
United Community Banks, Inc.
NASDAQ:UCB
|
$3.71 Billion |
|
Mazda Motor Corporation
PINK:MZDAF
|
$3.71 Billion |
|
Yuhan Corp Preferred
KO:000105
|
$3.71 Billion |
|
ASM Pacific Technology Limited
F:AY7A
|
$3.72 Billion |
|
MIRION TECHNOL. DL-0001
F:55I0
|
$3.71 Billion |
|
ALK-ABELLO AS DK -50
F:4AJ0
|
$3.71 Billion |
|
Anhui Yingliu
SHG:603308
|
$3.71 Billion |
|
GERDAU S.A. PFD
F:GDUB
|
$3.70 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hims Hers Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 344,029,000 to 476,716,000, a change of 132,687,000 (38.6%).
- Net income of 126,038,000 contributed positively to equity growth.
- Share repurchases of 83,039,000 reduced equity.
- Other comprehensive income decreased equity by 200,000.
- Other factors increased equity by 89,888,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $126.04 Million | +26.44% |
| Share Repurchases | $83.04 Million | -17.42% |
| Other Comprehensive Income | $-200.00K | -0.04% |
| Other Changes | $89.89 Million | +18.86% |
| Total Change | $- | 38.57% |
Book Value vs Market Value Analysis
This analysis compares Hims Hers Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 12.36x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 73.45x to 12.36x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $0.34 | $24.88 | x |
| 2019-12-31 | $-3.89 | $24.88 | x |
| 2020-12-31 | $-4.15 | $24.88 | x |
| 2021-12-31 | $1.79 | $24.88 | x |
| 2022-12-31 | $1.52 | $24.88 | x |
| 2023-12-31 | $1.64 | $24.88 | x |
| 2024-12-31 | $2.01 | $24.88 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Hims Hers Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 26.44%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.54%
- • Asset Turnover: 2.09x
- • Equity Multiplier: 1.48x
- Recent ROE (26.44%) is above the historical average (-51.96%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -330.10% | -282.03% | 0.56x | 2.08x | $-77.52 Million |
| 2019 | 0.00% | -87.29% | 1.15x | 0.00x | $-58.53 Million |
| 2020 | 0.00% | -12.18% | 1.25x | 0.00x | $-3.43 Million |
| 2021 | -32.17% | -39.60% | 0.65x | 1.26x | $-141.12 Million |
| 2022 | -21.07% | -12.46% | 1.44x | 1.18x | $-96.85 Million |
| 2023 | -6.84% | -2.70% | 1.98x | 1.28x | $-57.95 Million |
| 2024 | 26.44% | 8.54% | 2.09x | 1.48x | $78.37 Million |
Industry Comparison
This section compares Hims Hers Health Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $580,491,146
- Average return on equity (ROE) among peers: -45.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hims Hers Health Inc (HIMS) | $580.98 Million | -330.10% | 2.84x | $3.71 Billion |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $14.78 Million | -64.19% | 0.99x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-241.47K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -329.21% | 0.78x | $194.64 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $37.06 Million | 39.05% | 0.16x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $32.70 Million | -18.88% | 0.16x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.84 |
| Adcock Ingram Holdings Limited (AIHLF) | $4.54 Billion | 14.90% | 0.58x | $85.61 Million |